We aim to offer cancer patients a “second chance in life” by eliminating the term metastasis from the vocabulary of their primary tumour, giving them renewed hope and opportunities.
We strive to establish several meaningful partnerships to identify novel targets and molecules for metastasis and profile current anti-proliferation targets and candidates for metastasis. We also focus on developing companion diagnostics to identify the right clinical cohort for anti-metastasis study trials.
Mestastop Solutions combats metastasis with patented technology (proprietary in-vitro, in-vivo and ex-vivo platforms)and creating solutions for Drug Discovery, Drug Repurposing and Clinical Translation programs and studies.